Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
2.890
+0.040 (1.40%)
At close: Nov 4, 2024, 4:00 PM
2.929
+0.039 (1.35%)
After-hours: Nov 4, 2024, 6:33 PM EST
Sunshine Biopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -3.68 | -4.51 | -26.74 | -12.44 | -2.78 | -1.66 | Upgrade
|
| Depreciation & Amortization | 0.17 | 0.15 | 0.03 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 18.33 | - | - | - | Upgrade
|
| Stock-Based Compensation | 0.01 | - | - | 0.92 | 0.05 | 0.26 | Upgrade
|
| Other Operating Activities | - | - | -0.01 | 9.79 | 2.11 | 0.34 | Upgrade
|
| Change in Accounts Receivable | -2.41 | -0.59 | -0.52 | -0.01 | -0 | -0 | Upgrade
|
| Change in Inventory | -4.43 | -2.37 | 0.04 | -0.08 | -0.01 | -0.02 | Upgrade
|
| Change in Accounts Payable | 2.53 | -1.36 | 3.36 | -0.02 | -0.04 | -0.02 | Upgrade
|
| Change in Income Taxes | -1.17 | -0.07 | 0.24 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | -1.94 | -0.02 | 0.03 | -0 | 0 | 0 | Upgrade
|
| Operating Cash Flow | -10.91 | -8.78 | -5.25 | -1.83 | -0.66 | -0.5 | Upgrade
|
| Capital Expenditures | -0.66 | -0.08 | -0.19 | - | -0 | -0 | Upgrade
|
| Cash Acquisitions | - | - | -14.35 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.92 | -0.71 | -0.11 | - | - | - | Upgrade
|
| Other Investing Activities | 0.13 | 0.13 | 0.03 | - | - | -0.01 | Upgrade
|
| Investing Cash Flow | -1.46 | -0.66 | -14.62 | - | -0 | -0.02 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 3.32 | 1.67 | 0.47 | Upgrade
|
| Total Debt Issued | - | - | - | 3.32 | 1.67 | 0.47 | Upgrade
|
| Long-Term Debt Repaid | - | -0.13 | -1.93 | -0.48 | -0.11 | -0.05 | Upgrade
|
| Total Debt Repaid | -0.12 | -0.13 | -1.93 | -0.48 | -0.11 | -0.05 | Upgrade
|
| Net Debt Issued (Repaid) | -0.12 | -0.13 | -1.93 | 2.84 | 1.57 | 0.42 | Upgrade
|
| Issuance of Common Stock | 8.57 | 4.09 | 43.56 | - | - | - | Upgrade
|
| Repurchase of Common Stock | -3.17 | -0.54 | -0.1 | - | - | - | Upgrade
|
| Other Financing Activities | - | - | -2.06 | 0.06 | 0.04 | 0.03 | Upgrade
|
| Financing Cash Flow | 5.28 | 3.43 | 39.47 | 2.9 | 1.61 | 0.44 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1.13 | 0.47 | 0.18 | -0.02 | -0 | -0.01 | Upgrade
|
| Net Cash Flow | -8.22 | -5.53 | 19.78 | 1.06 | 0.95 | -0.07 | Upgrade
|
| Free Cash Flow | -11.57 | -8.86 | -5.44 | -1.83 | -0.66 | -0.5 | Upgrade
|
| Free Cash Flow Margin | -37.97% | -36.76% | -125.24% | -800.75% | -922.13% | -2351.49% | Upgrade
|
| Free Cash Flow Per Share | -434.21 | -728.04 | - | - | - | - | Upgrade
|
| Cash Interest Paid | - | - | 0.05 | 0.04 | 0.02 | - | Upgrade
|
| Levered Free Cash Flow | -11.57 | -8.2 | -4.35 | -0.91 | -0.44 | 0.64 | Upgrade
|
| Unlevered Free Cash Flow | -11.49 | -8.12 | -4.33 | -0.7 | -0.34 | 0.72 | Upgrade
|
| Change in Net Working Capital | 7.22 | 4.49 | -1.37 | 0.11 | 0.04 | -0.84 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.